For example, Cuthbert et al. (Cuthbert et al., 2022) analyzed the prediction of 8-year revision risk following total knee and hip arthroplasty, and Tang X et al. (Tang X. et al., 2021) studied prognostic prediction in metastatic non-small cell lung cancer patients receiving EGFR-TKI osiertinib treatment, both studies have proved that traditional statistical methods have certain strengths. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.